Foundation Stack

A combined research stack pairing a triple-receptor incretin compound with a tissue-repair peptide blend.

Contains: 1x Retatrutide 10mg, 1x KLOW Blend 80mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, 10mg KPV).

Studied in the context of

• Simultaneous activity at GLP-1, GIP and glucagon receptors — a "triple agonist" pharmacology profile under active investigation
• Appetite-signalling, energy-balance and glucose-dependent insulin pathways in metabolic research models
• Tissue repair, collagen production and wound healing pathways associated with GHK-Cu
• Inflammatory signalling regulation studied in connection with KPV
• Muscle, tendon, ligament and gastrointestinal healing pathways investigated for BPC-157
• Cell migration and tissue remodeling following injury studied for TB-500

Both components remain investigational compounds and are not approved medicines.

Retatrutide 10mg + KLOW Blend 80mg · For laboratory and research use only. Not for human or animal consumption. 18+ qualified researchers only.